logo

For the Inventor, By the Inventor

Seoul, South Korea

So-young Wang

This inventor holds 3 USPTO granted patents. Top assignee: Cj Corporation. Active years: 2005-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: So-young Wang. Retrieved from https://idiyas.com/inventor/so-young-wang-q4nfok3a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

% Patents Active = 33.3

Average Co-Inventor Count = 10.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal3 out of 53 
 
Cj Corporation
 patents

Years Active: 2005-2007

Loading Chart...
3 patents (USPTO):Explore Patents
1. 7169929 - Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor (2007-01-30),
2. 7135572 - Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor (2006-11-14),
3. 6946558 - Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor (2005-09-20),

Title: Innovator Spotlight: So-young Wang

Introduction: So-young Wang is a prominent inventor based in Seoul, South Korea, known for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of three patents, Wang has dedicated his career to developing innovative solutions that enhance health outcomes.

Latest Patents: Among his latest contributions to science, Wang has developed a series of diaryl 1,2,4-triazole derivatives that function as highly selective cyclooxygenase-2 inhibitors. The first patent details a novel diaryl 1,2,4-triazole derivative, characterized by specific structural components designated as R, W, and A, with the aim of providing therapeutic benefits through selective inhibition of the cyclooxygenase-2 enzyme. This innovative approach underscores his commitment to advancing medication efficacy.

Career Highlights: So-young Wang has demonstrated a sustained commitment to pharmaceutical research and development during his tenure at CJ Corporation. His work signifies an important milestone in the quest for targeted therapies, showcasing his ability to translate complex scientific concepts into practical applications.

Collaborations: Throughout his career, Wang has worked closely with notable colleagues, including Il-Hwan Cho and Jee-Woong Lim. Together, they have contributed to a collaborative environment that fosters innovation and accelerates the development of new medicinal compounds.

Conclusion: So-young Wang stands out as an influential figure in the realm of pharmaceutical invention with his innovative patents and collaborative spirit. His dedication to enhancing healthcare through targeted inhibitors marks a significant achievement in the industry, promising potential improvements in treatment options for various conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…